AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06308432 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: High temperature
Description: The performance test will be carried out in a room conditioned to a temperature of 35º.
Study NCT06308432 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: High humidity
Description: The performance test will be carried out in a room conditioned to 65% humidity.
Study NCT05723354 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: axillary block guided by ultrasound
Description: axillary block using local anesthetics
Study NCT05732662 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: SBRT
Description: 24-50Gy/8-12.5Gy/3-4f
Study NCT05732662 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cadonilimab
Description: 10 mg/kg,q3w
Study NCT06222697 — intervention group
Intervention type: DRUG
Intervention: Damoctocog-alfa-pegol (Jivi, BAY94-9027)
Description: Follow clinical practice/administration. No drug is provided to participants due to the observational nature of the study.
Study NCT05393401 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: VOP1k
Description: Photoplethysmographic records
Study NCT06578117 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Vision Training and Learning Task
Description: Participants will be seated at a computer, and will be shown a random-noise visual stimulus drifting in one of eight directions. Participants will be instructed to indicate the direction of motion they perceive using a Sony Access Controller or a computer keyboard. Sound cues during stimulus presentation will also be used to ensure participants are aware of stimulus onset during the training task.~After several repetitions of this visual training, a second set of visual cues will be presented to evaluate participant's learning of the program. Responses will be provided in the same manner by input from the controller or the keyboard.
Study NCT05638022 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Total cholesterol (TC) level test and direct Low density lipoprotein cholesterol (LDL-C) level test
Description: Total cholesterol (TC) level testing and direct Low density lipoprotein cholesterol (LDL-C) level testing will be performed in all 10,000 newborns enrolled in the project.
Study NCT05638022 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: DNA testing
Description: DNA testing (NGS analysis of DNA mutations in 9 genes: LDLR, APOB, APOE, PCSK9, LDLRAP1, STAP1, ABCG5, ABCG8, LIPA and polygenic markers) will be performed in the subcohort of 1,500 newborns with highest level of Low density lipoprotein cholesterol (LDL-C).
Study NCT04744571 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: aspirin, betaloc, atorvastatin, rosuvastatin, clopidogrel, ticagrelor
Description: Optimal medical therapy includes dual antiplatelet therapy and statins (aspirin, clopidogrel, ticagrelor, atorvastatin, rosuvastatin, betaloc). And optimal medical therapy should include adequate ventricular rate- limiting medication (i.e. Beta- blocker or rate-limiting calcium antagonist) where appropriate. Anti- anginal therapy should be used if the patients have symptom.
Study NCT04744571 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: aspirin, betaloc, atorvastatin, rosuvastatin, clopidogrel, ticagrelor
Description: Optimal medical therapy includes dual antiplatelet therapy and statins (aspirin, clopidogrel, ticagrelor, atorvastatin, rosuvastatin, betaloc). And optimal medical therapy should include adequate ventricular rate- limiting medication (i.e. Beta- blocker or rate-limiting calcium antagonist) where appropriate. Anti- anginal therapy should be used if the patients have symptom.
Study NCT04744571 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: coronary wires. or coronary balloons
Description: all species of coronary wires, or plain balloons
Study NCT04744571 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: coronary wires. or coronary balloons
Description: all species of coronary wires, or plain balloons
Study NCT04744571 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: drug-coated balloon
Description: Drug-coated balloon including all sizes and all brands
Study NCT04744571 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: drug-eluting stent
Description: Drug-eluting stent including all sizes and all brands
Study NCT05622825 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: DC-CIK
Description: To explore the therapeutic effect and safety of cryoablation combined with autologous DC-CIK (through hepatic artery infusion, HIA) for patients with advanced liver cancers
Study NCT04881461 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 5-grass mix SLIT-drops
Description: Sublingual allergy immunotherapy drops, for daily administration
Study NCT04881461 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT05563948 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cannabis
Description: Vaporized cannabis will be administered 3x/day for 15 days.
Study NCT05563948 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Cannabis
Description: Vaporized cannabis will be administered 3x/day for 15 days.
Study NCT06654947 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Surufatinib+Toripalimab+GEMOX
Description: Surufatinib (200mg，qd，Q3W）；Toripalimab(240mg IV d1, Q3W)；GEMOX：Gemcitabine: 1000 mg/m2, IV，d1，d8，Q3W，Oxaliplatin：100mg/m2,ivgtt，d1，Q3W）
Study NCT05001880 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Atezolizumab
Description: Given IV
Study NCT05001880 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Description: Given IV
Study NCT05001880 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Bevacizumab
Description: Given IV
Study NCT05001880 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo blood and tissue sample collection
Study NCT05001880 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Biospecimen Collection
Description: Undergo blood and tissue sample collection
Study NCT05001880 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: Given IV
Study NCT05001880 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Carboplatin
Description: Given IV
Study NCT05001880 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo CT scan
Study NCT05001880 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Computed Tomography
Description: Undergo CT scan
Study NCT05001880 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Cytoreductive Surgery
Description: Undergo surgery
Study NCT05001880 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Cytoreductive Surgery
Description: Undergo surgery
Study NCT05001880 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hyperthermic Intraperitoneal Chemotherapy
Description: Undergo HIPEC
Study NCT05001880 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Hyperthermic Intraperitoneal Chemotherapy
Description: Undergo HIPEC
Study NCT05001880 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pemetrexed
Description: Given IV
Study NCT05001880 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pemetrexed
Description: Given IV
Study NCT05001880 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Positron Emission Tomography
Description: Undergo PET scan
Study NCT05001880 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Positron Emission Tomography
Description: Undergo PET scan
Study NCT06678373 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Liaoning Chengda Inactivated Japanese Encephalitis Vaccine
Description: The patient needs to receive 1 dose of inactivated Japanese encephalitis vaccine.
Study NCT06678373 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Liaoning Chengda Inactivated Japanese Encephalitis Vaccine
Description: The patient needs to receive 2 doses of inactivated Japanese encephalitis vaccine, with an interval of 28 days.
Study NCT06678373 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Liaoning Chengda Inactivated Japanese Encephalitis Vaccine
Description: The patient needs to receive 2 doses of inactivated Japanese encephalitis vaccine, with an interval of 7 days.
Study NCT06626425 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Healthy Minds Program App
Description: An 8-week meditation-based well-being training containing content for each of the four pillars of the training program: Awareness, Connection, Insight, and Purpose.
Study NCT06626425 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Hydro Coach App
Description: The Hydro Coach app (HC). A smartphone-based wellness app to ensure proper hydration.
Study NCT06683560 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: : photopolymer resin material graphy Tera Harz 85 will be used to print 3D printed aligners for NAM treatment
Description: 3d printed NAM aligner is made from novel photopolymer resin as a novel device
Study NCT06717230 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: EverX Posterior
Description: Restoration
Study NCT06717230 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: EverX Posterior
Description: Restoration
Study NCT06725017 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Live SK08 powder
Description: SK08 is an investigational live biotherapeutic product containing a nontoxigenic B. fragilis(NTBF) strain as an active ingredient.
Study NCT06725017 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT06734156 — intervention group
Intervention type: OTHER
Intervention: No intervention: observational study
Description: No intervention: observational study
Study NCT06736067 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise
Description: Thirty minutes of exercise on a treadmill, including a 5-minute warm-up followed by increments in speed until reaching optimal moderate to high intensity (60-80% of age-predicted maximal heart rate), which will be maintained for 20 min, followed by a 5-minute cool-down. Age-predicted maximal HR will be defined as 220 beats-per-minute (BPM) minus age in years.
Study NCT06734611 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Fortified Iodized Salt with Folic Acid (FISFA)
Description: Addition of folic acid to iodized salt for daily consumption to assess folate levels.
Study NCT06735794 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Compressed iTBS
Description: Intermittent Theta-Burst Stimulation (iTBS) is a form of non-invasive brain stimulation that uses magnetic pulses applied to the scalp using a coil. iTBS will be used to stimulate the left motor cortex to enhance long-term potentiation (LTP)-like activity, a physiological mechanism associated with brain plasticity.~During the intervention, the study team will conduct two pre-iTBS TMS measurements (Pre-20 and Pre-10). Participants will then complete iTBS-c (active comparator), which will be delivered unilaterally to the left motor cortex. Following iTBS-c, five post-iTBS TMS measurements (Post-0, 15, 30, 45, and 60) will be obtained. Motor evoked potentials (MEPs) will be recorded from the right abductor pollicis brevis (APB) muscle to assess the effects of the stimulation.~The MCF-B65 (active iTBS) and Cool-B65 A/P (sham/active iTBS) TMS coils will be used, alongside the MagPro R30 or the MagPro X100 TMS stimulators to deliver the intervention.
Study NCT06735794 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Spaced iTBS
Description: Intermittent Theta-Burst Stimulation (iTBS) is a form of non-invasive brain stimulation that uses magnetic pulses applied to the scalp using a coil. iTBS will be used to stimulate the left motor cortex to enhance long-term potentiation (LTP)-like activity, a physiological mechanism associated with brain plasticity.~During the intervention, the study team will conduct two pre-iTBS TMS measurements (Pre-20 and Pre-10). Participants will then complete iTBS-s (experimental study intervention), which will be delivered unilaterally to the left motor cortex. Following iTBS-s, five post-iTBS TMS measurements (Post-0, 15, 30, 45, and 60) will be obtained. Motor evoked potentials (MEPs) will be recorded from the right abductor pollicis brevis (APB) muscle to assess the effects of the stimulation.~The MCF-B65 (active iTBS) and Cool-B65 A/P (sham/active iTBS) TMS coils will be used, alongside the MagPro R30 or the MagPro X100 TMS stimulators to deliver the intervention.
Study NCT06735794 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham iTBS
Description: Intermittent Theta-Burst Stimulation (iTBS) is a form of non-invasive brain stimulation that uses magnetic pulses applied to the scalp using a coil. iTBS will be used to stimulate the left motor cortex to enhance long-term potentiation (LTP)-like activity, a physiological mechanism associated with brain plasticity.~During the intervention, the study team will conduct two pre-iTBS TMS measurements (Pre-20 and Pre-10). Participants will then complete iTBS-sh (sham comparator), which will be delivered unilaterally to the left motor cortex. Following iTBS-sh, five post-iTBS TMS measurements (Post-0, 15, 30, 45, and 60) will be obtained. Motor evoked potentials (MEPs) will be recorded from the right abductor pollicis brevis (APB) muscle to assess the effects of the stimulation.~The MCF-P-B65 (sham iTBS), and Cool-B65 A/P (sham/active iTBS) TMS coils will be used, alongside the MagPro R30 or the MagPro X100 TMS stimulators to deliver the intervention.
Study NCT06736392 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Ultrasound guided Pericapsular Nerve Group Block
Description: With the patient in the supine position and the leg slightly abducted, a curvilinear transducer (2.5-7.5 MHz) is prepared with sterile conduction gel and covered with a sterile probe cover. The transducer is placed transversely over the anterior superior iliac spine (ASIS), then aligned with the pubic ramus and rotated approximately 45° parallel to the inguinal crease. The probe is slid medially to identify key landmarks: the anterior inferior iliac spine (AIIS), iliopubic eminence (IPE), iliopsoas tendon, femoral artery, and femoral nerve. Sliding the probe distally or tilting caudally exposes the femoral head.~A 20-22 gauge echogenic needle (100 mm) is inserted in-plane from lateral to medial, targeting the plane between the psoas tendon and the pubic ramus. the anesthetic agent is deposited to lift the psoas tendon while avoiding tendon puncture.
Study NCT06736392 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Isobaric Bupivacaine 0. 25%
Description: group c will receive PENG block with only 20ml isobaric bupivacaine 0.25%
Study NCT06736392 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 20 ml isobaric bupivacaine 0.25% and 1.5μg/kg dexmedetomidine
Description: group D will receive PENG block with 20 ml isobaric bupivacaine 0.25% and 1.5μg/kg dexmedetomidine
Study NCT06736392 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: the ultrasound machine with curvilinear transducer (high -frequency probe, 2.5Mhz to 7.5Mhz)
Description: the two groups will receive the PENG block under ultrasound guidance
Study NCT06736392 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: a standard echogenic 20-22 gauge 100mm needle
Description: the two groups will receive the PENG block using a standard echogenic 20-22 gauge 100mm needle
Study NCT04523350 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Instylla HES
Description: Instylla HES is a novel liquid embolic made of primarily water and polyethylene glycol (PEG)
Study NCT04523350 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: TAE or cTACE
Description: Bland TAE or cTACE
Study NCT05479890 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: ClientBot
Description: ClientBot is an AI-based simulated client that supports skills improvement for providers learning and using Motivational Interviewing
Study NCT06267989 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Extraction of the primary canine teeth
Description: Extraction of the primary teeth has show to be successful in some cases.
Study NCT06267989 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Expansion
Description: Expansion of the maxilla with rapid maxillary expander with no extractions
Study NCT05059158 — intervention group
Intervention type: RADIATION
Intervention: positron emission tomography (PET)
Description: 18-Flutemetamol PET (clinical indicated) is going to be performed at the visit.
Study NCT05856123 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SimPull Lateral Transfer Device
Description: Automated lateral transfer device
Study NCT05008926 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Naloxegol
Description: Administration of Naloxegol 25 mg per day by nasogastric tube (SNG) or orogastric tube (SOG). The administration should be started within the first 24 hours after the patient is admitted to intensive care and continued for the duration of the administration of the morphine derivative and until 48 hours after its discontinuation.
Study NCT05008926 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Administration of the placebo according to the same procedures as the experimental arm.
Study NCT05214417 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ketamine Injectable Solution
Description: 2 IM ketamine sessions with psychotherapy, spaced 9-15 days apart
Study NCT05214417 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Naturalistic Control
Description: Continuation of pre-existing conventional treatment
Study NCT05518903 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo CT
Study NCT05518903 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gallium Ga 68 FAPi-46
Description: Given IV
Study NCT05518903 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Positron Emission Tomography
Description: Undergo PET
Study NCT05327374 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: calculation of the inferior vena cava collapsibility index
Description: the ΔIVC was calculated by the emergency physician who was blinded from the patient's medical history using the formula ((IVCmax-IVCmin)/IVCmax) X100.A cutoff of 15% was used to define the presence(\<15%) or absence(>15%) of heart failure
Study NCT05199675 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Digital Peer Support Training Program
Description: The digital peer support training program will consist of bite size modules on the four active ingredients of youth mental well-being, which will be delivered through training workshops, simulation activities, and homework assignments. The training will be conducted over 8 sessions, each lasting for 45-60 minutes following the typical duration of a school lesson on Character and Citizenship Education. The training workshops will be conducted as part of the school's Character and Citizenship Education lessons. The proficiency of participants in applying these digital support skills will be evaluated through simulation and homework activities, in which they apply the four active ingredients in their responses to mock letters that are adapted from actual cases of peer emotional disclosure. At the end of the training, adolescents are expected to apply the four active ingredients to the homework assignments on peers' emotional experiences.
Study NCT05199675 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Digital Peer Support Training Program
Description: The digital peer support training program will consist of bite size modules on the four active ingredients of youth mental well-being, which will be delivered through training workshops, simulation activities, and homework assignments. The training will be conducted over 8 sessions, each lasting for 45-60 minutes following the typical duration of a school lesson on Character and Citizenship Education. The training workshops will be conducted as part of the school's Character and Citizenship Education lessons. The proficiency of participants in applying these digital support skills will be evaluated through simulation and homework activities, in which they apply the four active ingredients in their responses to mock letters that are adapted from actual cases of peer emotional disclosure. At the end of the training, adolescents are expected to apply the four active ingredients to the homework assignments on peers' emotional experiences.
Study NCT04654585 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: The STOP intervention
Description: The stop intervention is a heath professional (medical doctor) led intervention assisting smokers with low socioeconomic position in their smoking cessation attempt. It consists of routine care and adapted advice supplemented with a free delivery of any or several type(s) of nicotine replacement therapy (NRT) (patches, inhalers, gum, tablets, etc.) and/or an e-cigarette + e-liquid. The delivery of those smoking aids is based on the smokers' preference and choice.
Study NCT04654585 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard Care
Description: Participants randomised to the standard care group will be given standard care in assisting their smoking cessation attempt, but without free delivery of NRT or e-cigarettes.~Standard care includes motivational interviewing, advice to quit and prescription for NRTs. The number and online address of the French smoking cessation support helpline could also be provided. Health professionals will also be in position to prescribe NRT or other treatments (for example: Varenicline or Bupropion) which can help with smoking cessation, according to routine practice. The health professional could also give advice on e-cigarette use if he or she finds it suitable.